We demonstrated that, in contrast to classical opioid receptors, ACKR3 doesn't cause classical G protein signaling and is not modulated by the classical prescription or analgesic opioids, for instance morphine, fentanyl, or buprenorphine, or by nonselective opioid antagonists like naloxone. Rather, we proven that LIH383, an ACKR3-selective subnanomolar competitor https://derricko757nfu3.idblogz.com/profile